Back to Search Start Over

GPCRs as Emerging Cancer Drug Targets: Target Validation of oGPCR, GPR161 and its Role in Triple Negative Breast Cancer

Authors :
Ainhoa Nieto Gutierrez
Patricia McDonald
Source :
The FASEB Journal. 33
Publication Year :
2019
Publisher :
Wiley, 2019.

Subjects

Subjects :
business.industry
Cancer drugs
Genetics
Cancer research
Medicine
business
Molecular Biology
Biochemistry
Triple-negative breast cancer
Biotechnology
G protein-coupled receptor

Details

ISSN :
15306860 and 08926638
Volume :
33
Database :
OpenAIRE
Journal :
The FASEB Journal
Accession number :
edsair.doi...........b5c8bf52c49381d1f417c2934746e4e1

Tools

Authors Abstract Subjects Details